Could chemoprophylaxis be used as an HIV prevention strategy while we wait for an effective vaccine?
- 1 April 2003
- journal article
- other
- Published by Wolters Kluwer Health in AIDS
- Vol. 17 (6) , 937-938
- https://doi.org/10.1097/00002030-200304110-00027
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytesNature, 2002
- Predicting the unpredictable: Transmission of drug-resistant HIVNature Medicine, 2001
- Challenges and opportunities for development of an AIDS vaccineNature, 2001
- Efficacy of Postexposure Prophylaxis after Intravaginal Exposure of Pig-Tailed Macaques to a Human-Derived Retrovirus (Human Immunodeficiency Virus Type 2)Journal of Virology, 2000
- Condoms and seat belts: the parallels and the lessonsThe Lancet, 2000
- Effectiveness of Postinoculation ( R )-9-(2-Phosphonylmethoxypropyl)Adenine Treatment for Prevention of Persistent Simian Immunodeficiency Virus SIV mne Infection Depends Critically on Timing of Initiation and Duration of TreatmentJournal of Virology, 1998
- Prevention of SIV Infection in Macaques by ( R )-9-(2-Phosphonylmethoxypropyl)adenineScience, 1995
- Malaria Chemoprophylaxis for the TravelerNew England Journal of Medicine, 1993
- Vaccination with a live retrovirus: the nature of the protective immune response.Proceedings of the National Academy of Sciences, 1990
- Extensive variation of human immunodeficiency virus type-1 in vivoNature, 1988